Weekly Recap | EVEREST MED -14.31%, strategic deal fails to steady slideWeekly Review·Sep 12 at 05:25 AM01952+1.39%
Weekly Recap | EVEREST MED -1.54%, China approves CARDAMYSTWeekly Review·Sep 5 at 04:57 AM01952+1.39%
Weekly Recap | EVEREST MED +11.45%, interim report confirms profit swingWeekly Review·Aug 29 at 04:24 AM01952+1.39%
Weekly Recap | EVEREST MED +8.34%, mRNA vaccine hits Phase III endpointWeekly Review·Aug 22 at 06:52 AM01952+1.39%
